According to GuruFocus' list, these stocks have reached their 52-week highs.
International Flavors & Fragrances reached the 52-week high of $150.36
International Flavors & Fragrances Inc. (IFF, Financial) is engaged in manufacturing and supplying of flavors and fragrances for the food, beverage, personal care and household products industries either in the form of compounds or individual ingredients. International Flavors & Fragrances produces flavors and fragrances for food, beverage, household goods and personal care. International Flavors & Fragrances specializes in proprietary formulations, partnering with customers to deliver custom solutions. The company derives roughly half its sales from flavors and half from fragrances with a slightly higher share of profits coming from its flavors business. Along with Givaudan, Firmenich and Symrise, International Flavors & Fragrances is one of the Big Four flavor and fragrance companies.
The price of International Flavors & Fragrances shares has reached $150.36, which is 0.0% off the 52-week high of $150.38. International Flavors & Fragrances has a market cap of $11.87 billion; its shares were traded around $150.36 with a price-earnings (P/E) ratio of 30.38 and price-sales (P/S) ratio of 3.73. International Flavors & Fragrances' trailing 12-month dividend yield is 1.74%. The forward dividend yield is 1.84%. International Flavors & Fragrances had an annual average earnings growth of 6.60% over the past 10 years. GuruFocus rated International Flavors & Fragrances the business predictability rank of 3.5 stars.
Kite Pharma reached the 52-week high of $179.79
Kite Pharma Inc. (KITE, Financial) is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. In partnership with the National Cancer Institute through a cooperative research and development agreement, Kite is advancing a pipeline of proprietary product candidates, both chimeric antigen receptor and T-cell receptor products, targeting a wide range of cancer indicators. The company also has a strategic collaboration with Amgen to develop and commercialize next-generation CAR-T therapies.
The price of Kite Pharma shares has reached $179.79, which is 0.1% off the 52-week high of $179.95. Kite Pharma has a market cap of $10.31 billion; its shares were traded around $179.79 with and P/S ratio of 292.34.
Chairman, President and CEO Arie Belldegrun sold 26,347 shares for $179.66 per share on Sept. 25. The stock price has increased by 0.07% since.
Harris reached the 52-week high of $136.73
Harris Corp. (HRS, Financial) develops, manufactures and sells technology-based solutions that serve government and commercial customers' mission-critical challenges. Its products include communications systems, serving defense and public safety networks among other. Harris is a provider of electronic systems with applications in defense and civil government as well as commercial applications. The U.S. government and its contractors are the firm's largest customers. Its products include communications systems, serving defense and public safety networks; space and intelligence systems, providing Earth observation, environmental and geospatial solutions; and critical networks, for use in air traffic management, energy and maritime communications and ground network operations. A large majority of the firm's revenue is generated in the U.S.
The price of Harris shares has reached $136.73, which is 0.3% off the 52-week high of $137.17. Harris has a market cap of $16.29 billion; its shares were traded around $136.73 with a P/E ratio of 30.86 and P/S ratio of 2.62. Harris' trailing 12-month dividend yield is 1.58%. The forward dividend yield is 1.67%. Harris had an annual average earnings growth of 6.50% over the past 10 years.
Harris reported revenue of $1.54 billion in the fourth quarter of fiscal 2017 compared with $1.53 billion in the prior year. GAAP income from continuing operations was $166 million, or $1.35 per diluted share, compared with $142 million, or $1.13 per diluted share, in the prior year. Non-GAAP income from continuing operations was $183 million, or $1.49 per diluted share, compared with $163 million, or $1.30 per diluted share, in the prior year. Fourth-quarter orders were $1.57 billion with a book-to-bill of 1.02.
Fidelity National Information Services reached the 52-week high of $95.28
Fidelity National Information Services Inc. (FIS, Financial) offers a range of solutions in retail and institutional banking, payments, asset and wealth management, risk and compliance, treasury and insurance and provides consulting and outsourcing services. Fidelity provides core and payment processing services to banks. In addition, it provides processing software for capital markets providers, asset managers and custodians. The company serves more than 20,000 institutions in over 130 countries. North America accounts for 76% of revenue, EMEA another 15% while Asia accounts for 5% of total sales.
The price of Fidelity shares has reached $95.28, which is 0.2% off the 52-week high of $95.50. Fidelity has a market cap of $31.67 billion; its shares were traded around $95.28 with a P/E ratio of 47.88 and P/S ratio of 3.39. Fidelity's trailing 12-month dividend yield is 1.19%. The forward dividend yield is 1.22%. Fidelity had an annual average earnings growth of 7.20% over the past 10 years. GuruFocus rated Fidelity the business predictability rank of 3 stars.
The company recently reported that second-quarter GAAP revenue increased 1.5% to $2.341 billion from $2.305 billion in the prior-year quarter. Operating income increased to $359 million for the quarter from $283 million in the prior-year quarter while operating income margin was 15.3%. Net earnings from continuing operations attributable to common stockholders was $132 million for the quarter, or 40 cents per diluted share, compared to 36 cents per diluted share in the prior-year quarter.
PPG Industries reached the 52-week high of $117.76
PPG Industries Inc. (PPG, Financial) is engaged in manufacturing and distributing coatings, specialty materials and glass products. It sells its products to a wide variety of end users, including the automotive, aerospace, construction and industrial markets. PPG is a global producer of coatings and glass. The company is the world's largest producer of coatings after the purchase of selected AkzoNobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
The price of PPG shares has reached $117.76, which is 0.0% off the 52-week high of $117.80. PPG has a market cap of $30.2 billion; its shares were traded around $117.76 with a P/E ratio of 17.09 and P/S ratio of 2.10. PPG's trailing 12-month dividend yield is 1.40%. The forward dividend yield is 1.53%. PPG had an annual average earnings growth of 4.30% over the past 10 years. GuruFocus rated PPGÂ the business predictability rank of 3.5 stars.
PPG recently reported third quarter 2017 net sales of approximately $3.8 billion, up more than 3% versus the prior year. Third-quarter net income from continuing operations was $392 million, or $1.52 per diluted share, which includes an unfavorable natural disaster-related impact of approximately 5 cents. Third-quarter 2016 reported net loss from continuing operations was $211 million, or 79 cents per share. Third-quarter 2016 adjusted net income from continuing operations was $405 million, or $1.52 per share, excluding net after-tax charges totaling $616 million, or $2.31 per share, for pension settlement charges.
Disclosure: I do not own these stocks
